Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease  Stacey Ruiz, Pablo E. Pergola, Richard.

Slides:



Advertisements
Similar presentations
بسم الله الرحمن الرحيم.
Advertisements

Oxidative Stress and Atherosclerosis
2. dehydrogenases: there are a large number of enzymes in this class. They perform two main functions: 1. transfer of hydrogen from one substrate to another.
Toshio Miyata, Norio Suzuki, Charles van Ypersele de Strihou 
Pathways of liver injury in alcoholic liver disease
Volume 78, Issue 3, Pages (August 2010)
Volume 85, Issue 3, Pages (March 2014)
Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis  Hans-Joachim Anders, Mi Ryu 
Bart Staels, PhD  The American Journal of Medicine 
Carmen Peralta, Mónica B. Jiménez-Castro, Jordi Gracia-Sancho 
Hiroshi Tamura, M. D. , Ph. D. , Yasuhiko Nakamura, M. D. , Ph. D
Prevention of ischemia-reperfusion injury in cardiac surgery: Therapeutic strategies targeting signaling pathways  Kay Maeda, MD, PhD, Marc Ruel, MD,
Volume 85, Issue 2, Pages (January 2014)
Ulrich auf dem Keller, Angelika Kümin, Susanne Braun, Sabine Werner 
Recent insights on the mechanisms of liver preconditioning
Do reactive oxygen species play a role in myeloid leukemias?
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
Biochemical and physiological effects from exhaust emissions
Alcohol and mitochondria: A dysfunctional relationship
Oxidative stress in Alzheimer's disease
Role of Withania somnifera (Ashwagandha) in the management of male infertility  Pallav Sengupta, Ashok Agarwal, Maria Pogrebetskaya, Shubhadeep Roychoudhury,
Inhibition of cytochrome P450 2E1 and activation of transcription factor Nrf2 are renoprotective in myoglobinuric acute kidney injury  Zhe Wang, Sudhir.
Obstructive nephropathy: Insights from genetically engineered animals
ROS Function in Redox Signaling and Oxidative Stress
Volume 85, Issue 2, Pages (January 2014)
Biochemical and physiological effects from exhaust emissions
ROS Are Good Trends in Plant Science
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
P38 Mitogen Activated Protein Kinase Mediates Both Death Signaling and Functional Depression in the Heart  Meijing Wang, MD, Ben M. Tsai, MD, Mark W.
Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation  Adriana S. Dusso  Kidney International Supplements 
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
Paricalcitol attenuates cyclosporine-induced kidney injury in rats
Microbial Killing: Oxidants, Proteases and Ions
Figure 4 Mechanisms of leptin function on kidney injury
A “Reductionist” View of Cardiomyopathy
Volume 81, Issue 3, Pages (February 2012)
Pathways of liver injury in alcoholic liver disease
The SirT3 Divining Rod Points to Oxidative Stress
Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells  Stephanie F. Smith, Sarah A. Hosgood, Michael.
Carmen Peralta, Mónica B. Jiménez-Castro, Jordi Gracia-Sancho 
Ulrich auf dem Keller, Angelika Kümin, Susanne Braun, Sabine Werner 
Oxidative Stress in the Pathogenesis of Skin Disease
Volume 79, Issue 1, Pages (January 2011)
Volume 70, Issue 7, Pages (October 2006)
Sanjeev Noel, Abdel R.A. Hamad, Hamid Rabb  Kidney International 
Volume 76, Issue 11, Pages (December 2009)
Volume 67, Issue 1, Pages (January 2005)
Mechanism of steroid action in renal epithelial cells
Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury  Richard A. Zager,
Daniela Macconi, Giuseppe Remuzzi  Kidney International 
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Volume 70, Issue 10, Pages (November 2006)
Growth and development alter susceptibility to acute renal injury
Juliana Saraiva Anjos, MD, Ludmila F. M. F
Volume 83, Issue 4, Pages (April 2013)
Volume 70, Issue 4, Pages (August 2006)
Volume 79, Issue 2, Pages (January 2011)
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Hydrogen Peroxide Sensing and Signaling
Figure 2 Protective functions of HDL
The Duality of Angiogenesis: Implications for Therapy of Human Disease
Hydrogen: another gas with therapeutic potential
Angiotensin II: breathtaking in the renal medulla
NODding off in acute kidney injury with progranulin?
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 76, Issue 5, Pages (September 2009)
Sundararaman Swaminathan, Matthew D. Griffin  Kidney International 
Pathophysiologic pathways of hematuria-induced kidney damage.
WBCs Metabolism By Dr. Samar Kassim.
Christian Rask-Madsen, George L. King  Cell Metabolism 
Presentation transcript:

Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease  Stacey Ruiz, Pablo E. Pergola, Richard A. Zager, Nosratola D. Vaziri  Kidney International  Volume 83, Issue 6, Pages 1029-1041 (June 2013) DOI: 10.1038/ki.2012.439 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Production and metabolism of reactive oxygen species (ROS). Normally, over 95% of the oxygen consumed in the body is converted to water by acquisition of two electrons in a single step. However, for the remaining 5%, this process occurs with the transfer of one electron at a time, leading to formation of highly reactive and short-lived species, collectively referred to as ROS. The primary ROS produced in the body is superoxide, which is formed from single electron reduction of molecular oxygen. The primary sources of superoxide include the mitochondria, endoplasmic reticulum, cyclooxygenase, lipoxygenase, uncoupled nitric oxide synthase (NOS), NAD(P)H oxidase, xanthine oxidase, and cytochrome P450. Antioxidants then act on ROS to generate less reactive species. For example, superoxide dismutase (SOD) converts superoxide into hydrogen peroxide (H2O2), which is then reduced by catalase (CAT) into water and oxygen and by glutathione peroxidase (GPX) into water and oxidized glutathione. However, in pathological states, H2O2 serves as the substrate for formation of highly reactive and cytotoxic oxidants, such as hydroxyl radical by catalytically active iron (Fe2+) and hypochlorous acid by myeloperoxidase. An increase in ROS generation or decrease in antioxidant availability leads to oxidative stress and induction of the proinflammatory response, which contribute to disease pathogenesis. Kidney International 2013 83, 1029-1041DOI: (10.1038/ki.2012.439) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Nrf2 inhibits reactive oxygen species (ROS) and inflammatory pathways that lead to kidney dysfunction. Nrf2 is held in an inactive state bound to Keap1 in the cytoplasm. In response to oxidative stress signals from various sources, the Keap1/Nrf2 complex is disrupted, preventing degradation of Nrf2. As a result, newly synthesized Nrf2 translocates to the nucleus, where it activates the transcription of several antioxidant and detoxifying enzymes. Activation of Nrf2 also suppresses nuclear factor (NF)-κB activity, thereby inhibiting inflammation. AGE, advanced glycation end product; Ang II, angiotensin II; AT1/AT2, angiotensin II receptors; ICAM-1, intercellular adhesion molecule 1; IKKβ, IκB kinase; iNOS, inducible nitric oxide synthase; MCP-1, monocyte chemotactic protein-1; Nrf2, nuclear factor-erythroid-2-related factor 2; RAGE, receptor for advanced glycation end products; TGF-β1, transforming growth factor-β1; TNF-α, tumor necrosis factor-α; TNFR ,tumor necrosis factor receptor. Kidney International 2013 83, 1029-1041DOI: (10.1038/ki.2012.439) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Acute kidney injury leads to progressive renal disease and decline in anti-inflammatory heme oxygenase-1 (HO-1) and interleukin-10 (IL-10). (a) Following the induction of unilateral ischemic injury, a progressive loss of renal mass occurs over a 3-week period, culminating in a two-thirds reduction of renal weight (left panel). Progressive tubular injury during this period is underscored by a progressive increase in the mRNA for the biomarker protein neutrophil gelatinase-associated lipocalin (NGAL). A role for inflammation in this process is indicated by a progressive increase in proinflammatory cytokines, with stepwise increases in tumor necrosis factor-α (TNF-α) mRNA expression. Similar results were obtained for a proinflammatory chemokine, monocyte chemotactic protein-1 (MCP-1), as well as for a profibrotic cytokine, transforming growth factor-β1 (TGF-β1) (data presented in modified form from studies presented in Zager et al.136 and from RA Zager, unpublished data). BL, baseline value; one day (1 d), 1 week (1 wk), and 3 weeks (3 wks) after ischemia. The mRNA values were quantified by reverse transcriptase–PCR (RT–PCR) and were divided by simultaneously obtained glyceraldehyde 3-phosphate dehydrogenase (GAPDH) levels, used as a ‘housekeeping’ gene. (b) Whereas progressive renal disease and inflammation were noted over 3 weeks after ischemia (as shown in a), there was a relative failure of HO-1 expression. Although HO-1 protein levels rose at 1 day after ischemia, the levels fell over the ensuing 3 weeks. Even more marked reductions in anti-inflammatory IL-10 protein levels were observed. Thus, the falling anti-inflammatory protein levels, with rising expression of proinflammatory genes (as depicted in a), appear to represent reciprocal changes that tip the balance toward a proinflammatory/injury-promoting state (these results are from Agarwal et al.120 and from RA Zager, unpublished data). The HO-1 and IL-10 values are presented after factoring by total protein in the tissue extract. Kidney International 2013 83, 1029-1041DOI: (10.1038/ki.2012.439) Copyright © 2013 International Society of Nephrology Terms and Conditions